We are live on
!
Find out more
RBC
Ronald Blue & Co Portfolio holdings
AUM
$3.1B
1-Year Est. Return
12.82%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+12.82%
3 Year Est. Return
+2.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$39.4M
(+1.9%)
Cap. Flow
+$8.53M
Cap. Flow
% of AUM
0.41%
Top 10 Holdings %
Top 10 Hldgs %
86.38%
Holding
384
New
35
Increased
147
Reduced
150
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vident US Equity Strategy ETF
VUSE
|
+$55.3M |
| 2 |
Vident International Equity Strategy
VIDI
|
+$53.3M |
| 3 |
Vident US Bond Strategy ETF
VBND
|
+$22M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$7.02M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$6.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$75M |
| 2 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$27M |
| 3 |
iShares Gold Trust
IAU
|
+$10M |
| 4 |
Invesco DB Precious Metals Fund
DBP
|
+$6.22M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.05% |
| 2 | Financials | 1.8% |
| 3 | Consumer Staples | 1.6% |
| 4 | Energy | 1.58% |
| 5 | Industrials | 1.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vident International Equity Strategy
VIDI
$433M
| $726M | 34.63% |
30,691,311
+2,267,916
| +8% | +$53.3M |
|
|
2
Vident US Bond Strategy ETF
VBND
$523M
| $409M | 19.51% |
8,094,891
+438,109
| +6% | +$22M |
|
|
3
Vident US Equity Strategy ETF
VUSE
$675M
| $348M | 16.6% |
12,739,900
+2,054,216
| +19% | +$55.3M |
|
|
4
iShares Gold Trust
IAU
$62.9B
| $221M | 10.54% |
9,644,547
-424,781
| -4% | -$10M |
|
|
5
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
| $39.8M | 1.9% |
890,697
-1,705,095
| -66% | -$75M |
|
6
iShares MSCI ACWI ETF
ACWI
$32.9B
| $28M | 1.34% |
467,309
-28,694
| -6% | -$1.71M |
|
|
7
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
| $16M | 0.77% |
271,681
-466,643
| -63% | -$27M |
|
8
ExxonMobil
XOM
$644B
| $8.02M | 0.38% |
94,347
-26,809
| -22% | -$2.38M |
|
|
EGN
9
DELISTED
Energen
EGN
| $7.67M | 0.37% |
116,129
| – | – |
|
10
HCA Healthcare
HCA
$87.2B
| $7.33M | 0.35% |
97,463
-10,727
| -10% | -$770K |
|
|
11
Vanguard FTSE Europe ETF
VGK
$30.7B
| $7.07M | 0.34% |
+130,341
| New | +$7.02M |
|
12
Coca-Cola
KO
$377B
| $7M | 0.33% |
172,630
+3,951
| +2% | +$165K |
|
13
Apple
AAPL
$4.54T
| $6.38M | 0.3% |
205,112
-6,092
| -3% | -$184K |
|
|
LPNT
14
DELISTED
LifePoint Health, Inc.
LPNT
| $6.29M | 0.3% |
85,571
-313
| -0.4% | -$22.2K |
|
|
15
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $6.11M | 0.29% |
+126,502
| New | +$6.06M |
|
16
iShares MSCI EAFE ETF
EFA
$78B
| $5.75M | 0.27% |
89,670
+2,100
| +2% | +$132K |
|
17
Procter & Gamble
PG
$336B
| $5.57M | 0.27% |
67,936
-174
| -0.3% | -$15K |
|
18
Cullen/Frost Bankers
CFR
$10.3B
| $5.5M | 0.26% |
79,659
+45
| +0.1% | +$3.02K |
|
19
Eli Lilly
LLY
$1.02T
| $4.96M | 0.24% |
68,198
-6,435
| -9% | -$458K |
|
20
Dover
DOV
$27.6B
| $3.67M | 0.18% |
65,808
+9,474
| +17% | +$546K |
|
21
Chevron
CVX
$392B
| $3.65M | 0.17% |
34,720
+1,475
| +4% | +$157K |
|
|
22
Invesco DB Precious Metals Fund
DBP
$237M
| $3.6M | 0.17% |
97,572
-164,018
| -63% | -$6.22M |
|
23
Honeywell
HON
$77B
| $2.95M | 0.14% |
31,521
+4
| +0% | +$366 |
|
24
Verizon
VZ
$195B
| $2.86M | 0.14% |
58,859
-23,875
| -29% | -$1.15M |
|
25
iShares Core S&P 500 ETF
IVV
$878B
| $2.83M | 0.14% |
13,637
-2,655
| -16% | -$552K |
|
Similar funds
DL
VKH
CAM
TCM
HCM
AL
AT
1GA
Ronald Blue & Co's Q1 2015 Portfolio in Review
As of Q1 2015, Ronald Blue & Co held 384 positions worth $2.1B, up 1.9% from $2.06B the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Ronald Blue & Co's Q1 2015 filing shows 35 new, 147 increased, 150 reduced and 31 closed positions. Its largest new stake was Vanguard FTSE Europe ETF: 130,341 shares worth $7.07M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $75M.
By sector, the portfolio is most concentrated in Healthcare at 2% of assets, down from 2.1% a quarter earlier, followed by Financials and Consumer Staples.
- Ronald Blue & Co's largest Q1 2015 buy was Vanguard FTSE Europe ETF: 130,341 shares worth $7.07M.
- Ronald Blue & Co added most to Vident US Equity Strategy ETF in Q1 2015, an estimated $55.3M increase.
- Ronald Blue & Co's biggest Q1 2015 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $75M.
- Ronald Blue & Co fully exited PRECISION CASTPARTS CORP in Q1 2015, selling an estimated $463K.
- Ronald Blue & Co's ten largest holdings make up 86% of its $2.1B portfolio in Q1 2015.
- Ronald Blue & Co opened 35 new positions and closed 31 in Q1 2015.
- Ronald Blue & Co's portfolio value rose 1.9% quarter-over-quarter to $2.1B.
Based on Ronald Blue & Co's 13F filing for Q1 2015, filed 12 May 2015.